Cardiology Practices

Does Value Based Care Improve Cardiology?

Casting doubt on value based cardiac care, a JAMA study found that outpatient cardiology practices enrolled in an accountable care organization (ACO) through the Medicare Shared Savings Program (MSSP) don’t offer better care than non-ACO practices.

  • MSSP was introduced in 2012 to improve care quality and lower Medicare costs by having ACOs assume responsibility for Medicare beneficiaries’ costs and care quality.
  • As an incentive, Medicare then makes fee-for-service payments and shares the savings with ACOs if cost and care quality benchmarks are met.

Evaluating the ACO incentives, researchers compared care quality data from the ACC’s NCDR PINNACLE Registry before and 6-12 months after MSSP participation at 83 ACO outpatient cardiology practices versus 332 non-ACO practices and found…

  • MSSP ACO participation made no difference in coronary artery disease, HF, AFib, or hypertension outcomes.
  • No changes in CVD drug prescriptions, LDL profiles, or smoking cessation.
  • However, using a 24 month follow-up revealed increased beta-blocker use for HF (aOR: 1.23) as well as fewer patients with LDL profiles <100 mg/dL (0.71).

These results fly in the face of value based care’s promise to deliver better care, but the sub-analysis’ increased follow-up could suggest some benefits take longer to appear.

While their cardiac care benefits might not be clear, it’s worth remembering that ACOs are also intended to help save care costs.

  • One AHA study back in 2019 found that annual spending for Medicare beneficiaries with CVD was ≈$200 lower when cared for by ACO cardiologists, without sacrificing quality.

The Takeaway

While cardiology practices might not get better through joining an ACO, they do seem to get more cost effective. Maybe that’s not such a bad deal considering the U.S.’s annual health care costs for cardiovascular conditions are projected to almost quadruple to $1.5T by 2050.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiac Imaging June 16, 2025

Beyond Hardware: Is AI the Answer to Making Cardiac Imaging more Accessible? June 16, 2025

Sponsored by Philips Healthcare Cardiac imaging has traditionally improved through hardware advances, enabling the speed needed for high-quality images. However, hardware is rapidly reaching its physical limitations in suppressing cardiac motion and represents a large financial investment. Today, software and AI are driving the next leap in cardiac image quality and motion control – offering […]

Cardiology Pharmaceuticals June 12, 2025

FDA Approves a New BP Triple Polypill June 12, 2025

Bringing a more effective BP therapy to the U.S. market, the FDA approved George Medicines’ triple therapy polypill called Widaplik for patients with hypertension, making it the first of its kind to go to market in the U.S. Widaplik’s approval stems from two studies, including one comparing the polypill against placebo as an initial treatment […]

Cardiology Pharmaceuticals June 12, 2025

Pharmacologic Preconditioning to Improve Outcomes in Patients Undergoing Cardiac Surgery  June 12, 2025

The majority of patients undergoing cardiac surgery, especially those on cardiopulmonary bypass (CPB), experience post-operative complications such as new-onset atrial fibrillation (POAF) and acute kidney injury (AKI), largely driven by oxidative stress and inflammation.   Several approaches have been explored to reduce complications following cardiac surgery, however, a clinically meaningful impact has yet to be realized.  […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!